Date of event
Thursday, June 4, 2020 - 5:00 pm -
Thursday, June 4, 2020 - 6:00 pm
Continuing Education Credits
None

Content Contributor

AASLD COVID-19 Clinical Oversight & Publications Subcommittee

Presenters

  • Marina Serper, MD
    University of Pennsylvania Health System
  • Oren K. Fix, MD, MSc, FAASLD
    Swedish Medical Center
  • Elliot B. Tapper, MD
    University of Michigan Medical Center

Moderator

  • Nancy Reau, MD, FAASLD
    Rush University Medical Center

Panelists

  • Laura M. Kulik, MD
    Northwestern Medical Faculty Foundation
  • Jennifer C. Price, MD, PhD
    University of California, San Francisco
  • Andrew Reynolds
    San Francisco AIDS Foundation
  • Ashina Singh, MD
    Henry Ford Health System
  • Norah Terrault, MD, MPH, FAASLD
    Keck Medical Center of USC

Details

As the COVID-19 pandemic continues to evolve, AASLD is committed to helping our members and the broader community respond to increasing challenges and complexities.

This is the sixth in a series of webinars AASLD is dedicating to ongoing discoveries and discussions about COVID-19 and how it impacts the care of liver patients. Participants will be able to:

  • Identify recent changes in regulatory and financial barriers to telemedicine during the COVID-19 pandemic.
  • Discuss the integration of telemedicine and other innovative, technology-enabled approaches into care for patients with liver disease.
  • Consider and address the challenges of quality care delivery in a telemedicine-focused practice.
  • Recognize the disparities in telemedicine care delivery.
  • Consider the patient's perspective on telemedicine during the COVID-19 pandemic.

Attendees can submit their COVID-19 questions in advance via this survey. Our experts will select a few questions to discuss during the webinar. Questions must be received by Tuesday, June 2, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the live webinar, time permitting.

Presenter Bios

Marina Serper, MD

Marina Serper is Assistant Professor of Medicine at University of Pennsylvania Perelman School of Medicine and a physician at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia. She is a transplant hepatologist and a clinical and applied health services investigator focused on the design of patient-oriented and health-system-based interventions to improve care in liver disease and liver transplantation. Her most recent research focuses on telemedicine and care redesign for advanced liver disease.

Photo of Dr. Marina Serper


 

Oren K. Fix, MD, MSc, FAASLD

Dr. Oren Fix is the Medical Director of the Liver Transplant Program at Swedish Medical Center in Seattle, Washington and Clinical Associate Professor at the Washington State University Elson S. Floyd College of Medicine. He is an Associate Provider Informaticist at Providence St. Joseph Health and is board certified in Clinical Informatics and an Epic Physician Builder. He has served the AASLD as chair of the Training and Workforce and MOC Committees and currently serves on the Nominating Committee, Online Learning Committee, and the GI/Transplant Hepatology Pilot Steering Task Force. He is on the editorial boards of Liver Transplantation and Hepatology Communications. His research interests include alcohol-associated hepatitis and acute liver failure and he has more than 50 peer-reviewed publications and book chapters.

photo of Dr. Oren Fix


 

Elliot B. Tapper, MD

Dr. Elliot Tapper is Assistant Professor of Medicine at the University of Michigan Health System. Dr. Tapper’s research aims to improve the outcomes, quality of life and freedom from adverse events for patients with cirrhosis. His efforts focus on delineating quality indicators and developing interventions for the management and prevention of cirrhotic complications. He is currently Vice-Chair of the AASLD Practice Metrics Committee.

Together with Dr. Sumeet Asrani, he laid out a plan to anticipate and address the needs of patients with cirrhosis in the COVID-era in the paper entitled The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. His more than 150 original articles been published in journals including HEPATOLOGY, Journal of Hepatology, British Medical Journal, and the New England Journal of Medicine.

Photo of Dr. Elliot B. Tapper

Moderator Bio

Nancy Reau, MD, FAASLD

Nancy Reau, MD, is Professor of Internal Medicine, Richard B. Capps Chair of Hepatology, Associate Director of Solid Organ Transplantation, and Section Chief of Hepatology at Rush University Medical Center in Chicago, IL. She received her medical degree from The Ohio State University College of Medicine in Columbus, where she completed a residency and fellowship in gastroenterology/hepatology followed by a second fellowship in advanced transplant hepatology at Johns Hopkins Hospital in Baltimore, MD. Her primary research interests focus on viral hepatitis – from both a drug development and a clinical perspective - liver transplantation, and complications of chronic liver disease.

Prof. Reau has been an invited lecturer at numerous presentations focused on viral hepatitis, fatty liver disease, cirrhosis, and liver transplantation. Prof. Reau is a fellow of the American Gastroenterological Association and American Association for the Study of Liver Diseases (AASLD). Additionally, she is the current editor in chief of CLD (Clinical Liver Disease) and was an author of the AASLD/IDSA hepatitis C guidance document. She was the committee chair of the AASLD public policy committee and a member of the AASLD practice guideline committee for four years.

Prof. Reau has authored or coauthored more than 100 peer-reviewed articles that have been published in journals such as Hepatology, Hepatitis Research and Treatment, and Clinics in Liver Disease. She is Co-chair of the National ALF Medical Advisory Committee and sits on multiple advisory boards.. She is currently a member of the steering committee for the hepatitis C special interest group (SIG) for the American Association for the Study of Liver Diseases (AASLD) and a member of the ACG training committee

Photo of Dr. Nancy Reau